Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 14. Antiinflamatorios no esteroideos, antirreumáticos, y agentes mineralizantes | No observations |
| Belize. National Drug Formulary | 02.04 Chronic gout | No observations |
| Belize. National Drug Formulary | 04.02. Specific | No observations |
| List | Section | Observation |
|---|---|---|
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: X 30 CAPSULAS |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | M. SISTEMA MUSCULOESQUELÉTICO | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 02.04. ANTIRREUMATICOS NO ESTEROIDALES | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 64:00 Antidotes/Metal Antagonists | No observations |
| Suriname. NGK-C-011 | 2.4 Anti-gout agents and agents for Rheumatic diseases | No observations |
| Suriname. NGK-C-011 | 4.2 Specific | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 64.0 Heavy Metal Antagonists | No observations |
| Belize. National Drug Formulary | 02.04 Chronic gout | No observations |
| Belize. National Drug Formulary | 04.02. Specific | No observations |
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 26.10. INTOXICACION CON METALES PESADOS | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 4.2. Specific |
Others observations: The Expert Committee has requested a review of the comparative effectiveness and safety, for possible deletion of this medicine at its next meeting. |
| WHO Model List of Essential Medicines (2021) | 29.2 Disease-modifying anti-rheumatic drugs (DMARDs) | No observations |
| Peru | 2.4 Anti-Rheumatics | No observations |
| Peru | 4.2 Specifics | No observations |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 14. Antiinflamatorios no esteroideos, antirreumáticos, y agentes mineralizantes | No observations |
| Haiti. National List of Essential Medicines | 30.02. Disease modifying agents used in rheumatoid arthritis | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 11. INTOXICACIONES | No observations |
| List | Section | Observation |
|---|---|---|
| Belize. National Drug Formulary | 02.04 Chronic gout | No observations |
| Belize. National Drug Formulary | 04.02. Specific | No observations |
| List | Section | Observation |
|---|---|---|
| Chile. Formulario Nacional de Medicamentos. 2005 | 04. ANTÍDOTOS Y OTRAS SUBSTANCIAS USADAS EN EL TRATAMIENTO DE INTOXICACIONES | No observations |
| Belize. National Drug Formulary | 02.04 Chronic gout | No observations |
| Belize. National Drug Formulary | 04.02. Specific | No observations |